谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Nivolumab Plus Chemotherapy in Patients with HER2-negative, Previously Untreated, Unresectable, Advanced, or Recurrent Gastric/gastroesophageal Junction Cancer: 3-Year Follow-Up of the ATTRACTION-4 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial.

Narikazu Boku,Takeshi Omori,Kohei Shitara,Shinichi Sakuramoto,Kensei Yamaguchi,Ken Kato,Shigenori Kadowaki,Kunihiro Tsuji,Min-Hee Ryu,Do-Youn Oh,Sang Cheul Oh,Sun Young Rha,Keun-Wook Lee,Ik-Joo Chung,Sun Jin Sym,Li-Tzong Chen,Jen-Shi Chen,Li-Yuan Bai, Takashi Nakada,Shunsuke Hagihara, Reina Makino, Eiji Nishiyama,Yoon-Koo Kang

GASTRIC CANCER（2024）

引用 0|浏览11
关键词
Gastric cancer,Chemotherapy,Nivolumab,Oxaliplatin,Randomized controlled trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要